Inhibrx Biosciences (INBX) Receivables: 2023-2025
Historic Receivables for Inhibrx Biosciences (INBX) over the last 2 years, with Sep 2025 value amounting to $837,000.
- Inhibrx Biosciences' Receivables rose 24.55% to $837,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year change of. This contributed to the annual value of $397,000 for FY2024, which is 71.34% down from last year.
- Inhibrx Biosciences' Receivables amounted to $837,000 in Q3 2025, which was down 13.44% from $967,000 recorded in Q2 2025.
- In the past 5 years, Inhibrx Biosciences' Receivables ranged from a high of $1.4 million in Q4 2023 and a low of $214,000 during Q1 2025.
- For the 3-year period, Inhibrx Biosciences' Receivables averaged around $813,571, with its median value being $837,000 (2025).
- As far as peak fluctuations go, Inhibrx Biosciences' Receivables slumped by 71.34% in 2024, and later climbed by 24.55% in 2025.
- Quarterly analysis of 3 years shows Inhibrx Biosciences' Receivables stood at $1.4 million in 2023, then plummeted by 71.34% to $397,000 in 2024, then increased by 24.55% to $837,000 in 2025.
- Its Receivables was $837,000 in Q3 2025, compared to $967,000 in Q2 2025 and $214,000 in Q1 2025.